Kristie L. Kahl

The phase 3 TIVO-3 trial – designed to evaluate the efficacy of Fotivda in patients with renal cell carcinoma – met its primary endpoint of improved progression-free survival.

Lawrence D. Kaplan, M.D., discusses recent updates and next steps to be taken in Hodgkin, mantle cell and follicular lymphoma.

The Food and Drug Administration granted a priority review to Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for the frontline treatment of unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) in patients whose disease expresses the PD-L1 protein, as determined by PD-L1 biomarker testing, according to Roche, the drug’s manufacturer.

Entospletinib monotherapy yielded limited activity in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma.

At a local event, Shannon Pulaski – author of Mom’s Genes – shared her journey after being diagnosed with the BRCA mutation.

A panel of caregivers drew upon personal experience to offer advice and ideas to those in this role.

A new American Cancer Society guideline recommends starting screening for colorectal cancer at age 45.

In this week’s episode of CURE Talks Cancer, we spoke with Jill Kelly – wife of Pro Football Hall of Fame Quarterback Jim Kelly – about his bout with head and neck cancer, and how she copes as a caregiver.

SINGER ARETHA FRANKLIN, 76, died of advanced pancreatic cancer on Aug. 16 at her home in Detroit, with her family and friends at her bedside.

The Food and Drug Administration (FDA) granted fast track designation to selinexor for the treatment of patients with diffuse large B-cell lymphoma (DLBCL), according to Karyopharm Therapeutics, the drug’s manufacturer.

The Food and Drug Administration (FDA) approved Udenyca (pegfilgrastim-cbqv), a biosimilar to Neulasta (pegfilgrastim), according to Coherus Biosciences, the biosimilar’s manufacturer.

The Food and Drug Administration (FDA) granted accelerated approval to Lorbrena (lorlatinib) for the treatment of patients with ALK-positive, metastatic non-small cell lung cancer (NSCLC) who progressed on one or more ALK tyrosine kinase inhibitor (TKI), according to Pfizer, the drug’s manufacturer.

With the click of a button, patients can pave the way for lung cancer research, too.

In this episode of CURE Talks Cancer, former NFL running back and radio host Tiki Barber shares his mother’s journey with breast cancer and the impact it had on his life.

The Food and Drug Administration has granted a priority review to the supplemental new drug application for Jakafi (ruxolitinib) to treat patients with acute graft-versus-host-disease (GVHD) who have had an inadequate response to corticosteroids.

The replacement of vincristine with Velcade (bortezomib) in the R-CHOP regimen for the treatment of transplantation-ineligible patients with newly diagnosed mantle cell lymphoma improved overall survival in a final analysis of the LYM-3002 trial.

A recent study found that fatigue reported among newly diagnosed patients with multiple myeloma may predict survival outcomes.

Actress partners with TESARO to launch national movement to help empower the ovarian cancer community

Preliminary findings showed that Revlimid (lenalidomide) significantly prolonged progression-free survival compared with observation in patients with smoldering multiple myeloma.

A blood test may help to identify a subset of patients with mantle cell lymphoma and determine the management of outcomes of these individuals.

After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.

In a recent survey, individuals in remission reported a more positive experience with bladder cancer compared with their counterparts who currently have active disease.

The Food and Drug Administration (FDA) approved Khapzory (levoleucovorin) injection, a folate analog for three indications.

To combat the psychological effects from a lymphedema diagnosis, patients need to be equipped with the knowledge and understanding of what the condition is and how it is treated.

One family shares their experience with the discovery of a BRCA mutation, and how they discussed it among one another.

Exercise and nutrition are essential to improving a variety of facets revolving around the continuum of cancer — from prevention to diagnosis and treatment to survivorship care.

A genetic counselor discussed the various hereditary breast and ovarian cancer syndrome-associated cancers among men and how to manage them at the FORCE Annual Meeting.

Imagine receiving two pieces of life-altering news in a matter of three days. One survivor not only experienced this, but came out the other side with a positive outlook and a humorous book, too.

In this episode of CURE Talks Cancer, we caught up with all three storytellers from the “Our Way Forward: Stories that Illuminate the Ovarian Cancer Experience,” storytelling event hosted through a special engagement with The Moth.

As part of the Bristol-Myers Squibb Coast 2 Coast 4 Cancer Research ride, 109 company employees rode from Oregon to New Jersey to help raise funds for the V Foundation for Cancer Research.